Literature DB >> 22983456

A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures.

Arpita Thakker1, Preeti Shanbag.   

Abstract

The objective of this study is to compare the safety and efficacy of midazolam given intranasally with diazepam given intravenously in the treatment of acute childhood seizures. A randomized controlled study was conducted in a pediatric emergency department in a tertiary general hospital. Fifty children aged from 1 month to 12 years presenting with acute seizures of at least 10 min duration were enrolled during a 12 month period. Intranasal midazolam (0.2 mg/kg) and intravenous diazepam (0.3 mg/kg) were administered. The main outcome measures were interval between arrival at hospital and starting treatment and interval between arrival at hospital and cessation of seizures. Intranasal midazolam and intravenous diazepam were equally effective. Overall 18 of 27 seizures were controlled with midazolam and 15 of 23 with diazepam. The mean interval between arrival at hospital and starting treatment was significantly shorter in the midazolam group [3.37 min (SD 2.46)] as compared to the diazepam group [14.13 min (SD 3.39)]. The mean interval between cessation of seizures and arrival at hospital was significantly shorter in the midazolam group [6.67 min (SD 3.12)] as compared to the diazepam group [17.18 min (SD 5.09)]. The mean interval between control of seizures and administration of the drug was shorter in the diazepam group [2.67 min (SD 2.31)] as compared to the midazolam group [3.01 min (SD 2.79)]. No significant side effects were observed in either group. Seizures were controlled more quickly with intravenous diazepam than with intranasal midazolam. Midazolam was as safe and effective as diazepam. The overall interval between arrival at hospital and cessation of seizures was shorter with intranasal midazolam than with intravenous diazepam. The intranasal route can be possibly used not only in medical centres, but with appropriate instruction by the parents of children with acute seizures at home.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983456     DOI: 10.1007/s00415-012-6659-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Intranasal midazolam for childhood seizures.

Authors:  E Lahat; M Goldman; J Barr; G Eshel; M Berkovitch
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

2.  Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus.

Authors:  K O Nakken; M I Lossius
Journal:  Acta Neurol Scand       Date:  2011-01-06       Impact factor: 3.209

3.  Nasal midazolam and ketamine for paediatric sedation during computerised tomography.

Authors:  A Louon; V G Reddy
Journal:  Acta Anaesthesiol Scand       Date:  1994-04       Impact factor: 2.105

4.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

5.  Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study.

Authors:  E Lahat; M Goldman; J Barr; T Bistritzer; M Berkovitch
Journal:  BMJ       Date:  2000-07-08

6.  Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.

Authors:  John McIntyre; Sue Robertson; Elizabeth Norris; Richard Appleton; William P Whitehouse; Barbara Phillips; Tim Martland; Kathleen Berry; Jacqueline Collier; Stephanie Smith; Imti Choonara
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

7.  A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children.

Authors:  J M Chamberlain; M A Altieri; C Futterman; G M Young; D W Ochsenschlager; Y Waisman
Journal:  Pediatr Emerg Care       Date:  1997-04       Impact factor: 1.454

8.  Benzodiazepines protect mice from local anesthetic convulsions and deaths.

Authors:  R H de Jong; J D Bonin
Journal:  Anesth Analg       Date:  1981-06       Impact factor: 5.108

9.  In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution.

Authors:  D J Greenblatt; R M Arendt; D R Abernethy; H G Giles; E M Sellers; R I Shader
Journal:  Br J Anaesth       Date:  1983-10       Impact factor: 9.166

10.  A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations.

Authors:  Gerrit-Jan de Haan; Peter van der Geest; Gerard Doelman; Edward Bertram; Peter Edelbroek
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

View more
  18 in total

Review 1.  Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.

Authors:  Sandesh D Reddy; Doodipala Samba Reddy
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

Review 2.  A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus.

Authors:  Francesco Brigo; Raffaele Nardone; Frediano Tezzon; Eugen Trinka
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

Review 3.  Outpatient pharmacotherapy and modes of administration for acute repetitive and prolonged seizures.

Authors:  Heather Ravvin McKee; Bassel Abou-Khalil
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

4.  Intranasal midazolam for seizure cessation in the community setting.

Authors:  Michal Zelcer; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

5.  Preparation of Nanocrystals for Insoluble Drugs by Top-Down Nanotechnology with Improved Solubility and Bioavailability.

Authors:  Xun Zhang; Zhiguo Li; Jing Gao; Zengming Wang; Xiang Gao; Nan Liu; Meng Li; Hui Zhang; Aiping Zheng
Journal:  Molecules       Date:  2020-02-28       Impact factor: 4.411

Review 6.  Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Richard E Rosch; Jo M Wilmshurst; Arjune Sen; Georgia Ramantani; Colin J Akerman; Joseph V Raimondo
Journal:  Nat Rev Neurol       Date:  2022-05-10       Impact factor: 44.711

Review 7.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

Review 8.  New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective.

Authors:  Marco Mula
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

Review 9.  Pharmacotherapy for Status Epilepticus.

Authors:  Eugen Trinka; Julia Höfler; Markus Leitinger; Francesco Brigo
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 10.  Rescue therapies for seizure emergencies: current and future landscape.

Authors:  Debopam Samanta
Journal:  Neurol Sci       Date:  2021-07-16       Impact factor: 3.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.